Los puntos clave no están disponibles para este artículo en este momento.
An overall ROS1 fusion frequency of 2.59% was confirmed in this study. ROS1 fusion was more prevalent among younger patients, never-smokers, and those at advanced node stages.
Zhang et al. (Fri,) studied this question.